Seer, Inc. (California) (SEER)
2.04
-0.04
(-1.92%)
USD |
NASDAQ |
Oct 15, 16:00
2.045
0.00 (0.00%)
After-Hours: 20:00
Seer Research and Development Expense (Quarterly) : 8.209M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.209M |
| March 31, 2026 | 8.806M |
| December 31, 2025 | 9.742M |
| September 30, 2025 | 10.80M |
| June 30, 2025 | 11.98M |
| March 31, 2025 | 11.35M |
| December 31, 2024 | 11.01M |
| September 30, 2024 | 12.97M |
| June 30, 2024 | 11.23M |
| March 31, 2024 | 10.77M |
| December 31, 2023 | 9.585M |
| September 30, 2023 | 11.73M |
| June 30, 2023 | 12.79M |
| March 31, 2023 | 13.17M |
| Date | Value |
|---|---|
| December 31, 2022 | 11.07M |
| September 30, 2022 | 10.50M |
| June 30, 2022 | 9.97M |
| March 31, 2022 | 9.857M |
| December 31, 2021 | 6.374M |
| September 30, 2021 | 7.065M |
| June 30, 2021 | 6.375M |
| March 31, 2021 | 5.745M |
| December 31, 2020 | 4.948M |
| September 30, 2020 | 4.331M |
| June 30, 2020 | 4.317M |
| March 31, 2020 | 3.945M |
| December 31, 2019 | 3.605M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Champions Oncology, Inc. | 2.344M |
| Medpace Holdings, Inc. | -- |
| Avantor, Inc. | -- |
| Personalis, Inc. | 16.34M |
| Adaptive Biotechnologies Corp. | 18.30M |